How gut bacteria affect cancer immunotherapy response

Researchers want to understand whether the natural bacteria living in your gut—your microbiome—can predict how well you'll respond to immune checkpoint inhibitor therapy, a type of cancer treatment that helps your immune system fight tumors. This is an observational study, meaning researchers will follow you over time and collect stool samples to study your gut bacteria, rather than giving you a new medication to test. The goal is to learn whether changing diet, exercise, or taking probiotics might help these cancer treatments work better.

Some people respond very well to immune-based cancer treatments while others don't, and doctors don't yet have a reliable way to predict who will benefit. Early research suggests that the type and balance of bacteria in your gut may play a role in how your immune system responds to this medication, so this study aims to understand that connection with larger groups of patients.